Latest Articles
DESTINY-Endometrial02 Phase 3 Trial of ENHERTU® Initiated as Adjuvant Therapy in Patients with HER2 Expressing Endometrial Cancer - itemonline.com
DESTINY-Endometrial02 Phase 3 Trial of ENHERTU® Initiated as Adjuvant Therapy in Patients with HER2 Expressing Endometrial Cancer itemonline.com
Published: Dec. 22, 2025, 7:30 a.m.
Adjuvant Chemoradiotherapy Provides Long-Term Survival Benefits in High-Risk Endometrial Cancer - OncLive
Adjuvant Chemoradiotherapy Provides Long-Term Survival Benefits in High-Risk Endometrial Cancer OncLive
Published: Dec. 22, 2025, 5:26 a.m.
New Combination Therapy Shows Promise for pMMR Advanced Endometrial Cancer in Phase Ib/II Trial - geneonline.com
New Combination Therapy Shows Promise for pMMR Advanced Endometrial Cancer in Phase Ib/II Trial geneonline.com
Published: Dec. 21, 2025, 12:34 p.m.
Fruquintinib and Sintilimab Treat Advanced Endometrial Cancer - Bioengineer.org
Fruquintinib and Sintilimab Treat Advanced Endometrial Cancer Bioengineer.org
Published: Dec. 21, 2025, 11:59 a.m.
Brian Slomovitz: New Study on PARP Therapy Advances in Endometrial Cancer - Oncodaily
Brian Slomovitz: New Study on PARP Therapy Advances in Endometrial Cancer Oncodaily
Published: Dec. 19, 2025, 7:56 p.m.
The Molecular Classification Ushers in a New Era for the Treatment of Advanced and Recurrent Endometrial Cancer - Frontiers
The Molecular Classification Ushers in a New Era for the Treatment of Advanced and Recurrent Endometrial Cancer Frontiers
Published: Dec. 18, 2025, 3:05 p.m.
Immunotherapy in Endometrial Cancer: Mechanisms, Clinical Evidence, and Future Directions - Frontiers
Immunotherapy in Endometrial Cancer: Mechanisms, Clinical Evidence, and Future Directions Frontiers
Published: Dec. 17, 2025, 5:24 p.m.
Endometrial cancer patient advocate reinforces the importance of normalizing conversations about symptoms - Fred Hutchinson Cancer Center
Endometrial cancer patient advocate reinforces the importance of normalizing conversations about symptoms Fred Hutchinson Cancer Center
Published: Dec. 16, 2025, 11:04 p.m.
Study Links Oleic Acid to Tumor Growth in Endometrial Cancer Through Polyamine Accumulation - geneonline.com
Study Links Oleic Acid to Tumor Growth in Endometrial Cancer Through Polyamine Accumulation geneonline.com
Published: Dec. 16, 2025, 10:36 p.m.
Study Identifies FABP7 Protein as a Driver of Mobility and Stemness in Endometrial Cancer Cells - geneonline.com
Study Identifies FABP7 Protein as a Driver of Mobility and Stemness in Endometrial Cancer Cells geneonline.com
Published: Dec. 16, 2025, 10:35 p.m.
Link copied to clipboard!